Could blood from a cancer's own vein reveal more tumor DNA?
NCT ID NCT05497531
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study compares two ways of collecting blood to detect circulating tumor DNA (ctDNA) in people with liver or pancreatic cancers. Researchers will take blood from a standard arm vein and also from the vein that drains directly from the tumor during a biopsy. The goal is to see if the tumor-draining vein sample contains more or different tumor DNA. Only 15 participants are being enrolled, so this is an early-stage exploration.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more sensitive way to detect tumor DNA, potentially improving cancer monitoring and treatment decisions.
- What could go wrong
- This is a very small pilot study with only 15 participants, so results may not apply broadly. The procedure is also more invasive than a standard blood draw.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMPULLARY CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Chao Family Comprehensive Cancer Center, University of California, Irvine
RECRUITINGOrange, California, 92868, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Could a tailored diet before surgery boost liver cancer recovery?
- MRI might reveal hidden pancreatic risks in obesity